RxDoctor Payments Data

Eyitayo Odeniyi

Psychiatric/Mental Health · San Antonio, TXNPI 1215398532

Payments from drug & device makers

$1,791in general payments, 2019–2025

Across 93 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$624
  • Neurocrine Biosciences, Inc.$436
  • Acadia Pharmaceuticals Inc$345
  • Teva Pharmaceuticals USA, Inc.$298
  • Avanir Pharmaceuticals, Inc.$46
  • Alkermes, Inc.$27
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$1,791100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,791 in reported general payments places this provider in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$291,066
Medicare patients
298
Services billed
3,271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$72,458
Memantine Hcl ErMemantine Hcl58$6,684
RexultiBrexpiprazole14$6,082
Trazodone Hcl357$4,037
Memantine Hcl143$4,016
Divalproex Sodium176$3,525
Donepezil Hcl233$2,491
Duloxetine Hcl69$2,164
Mirtazapine113$2,051
Buspirone Hcl74$1,973
Sertraline Hcl170$1,817
Lorazepam95$1,580
Clonazepam74$1,426
Alprazolam39$1,052
Olanzapine58$1,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$298$72,45823 claims
Otsuka America Pharmaceutical, Inc.Rexulti$624$6,08214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →